Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
HAMBURG, DE / ACCESS Newswire / May 4, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the nomination of a small molecule preclinical development candidate (PDC) from its ...
Fractyl Health to present preclinical data on gene therapy for obesity and type 2 diabetes at ADA’s Scientific Sessions. Fractyl Health, Inc. has announced it will present new preclinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results